Source: wikipedia.org; (CC BY-SA 3.0)
Goldman Sachs has named employee of Morgan Stanley, Samuel Thong, as the Chairman of “the healthcare group” for the Asian banks while Japan “investment banking division” being the exception, reported people familiar with the decision.
Furthermore, Thong will also serve as the joint head of Goldman Sachs’ “healthcare group in Asia excluding-Japan”, while he is scheduled to take up his new responsibilities from the following month, informed the sources, requesting anonymity since the news has not been made public yet.
According to Reuters:
“Before covering healthcare investment banking in Asia at Morgan Stanley, Thong worked at Bank of America Merrill Lynch, according to the people and the information available in his LinkedIn profile”.
Nevertheless, a spokesperson of Goldman Sachs, Hong Kong, has confirmed the news of Thong’s hiring. The said step of Goldman Sachs comes at a time when we observe, “a surge in healthcare deals in the region”, especially in “Chinese firms such as Hansoh Pharmaceutical Group that raised roughly $1 billion this month in an IPO”.
References:
reuters.com
Furthermore, Thong will also serve as the joint head of Goldman Sachs’ “healthcare group in Asia excluding-Japan”, while he is scheduled to take up his new responsibilities from the following month, informed the sources, requesting anonymity since the news has not been made public yet.
According to Reuters:
“Before covering healthcare investment banking in Asia at Morgan Stanley, Thong worked at Bank of America Merrill Lynch, according to the people and the information available in his LinkedIn profile”.
Nevertheless, a spokesperson of Goldman Sachs, Hong Kong, has confirmed the news of Thong’s hiring. The said step of Goldman Sachs comes at a time when we observe, “a surge in healthcare deals in the region”, especially in “Chinese firms such as Hansoh Pharmaceutical Group that raised roughly $1 billion this month in an IPO”.
References:
reuters.com